Susquehanna International Group, LLP Avadel Pharmaceuticals PLC Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$12.55 - $17.22 $3.1 Million - $4.25 Million	247,000 Added 61.05%	651,600 $11 Million
Q4 2023 Feb 14, 2024	BUY	$9.64 - $14.59 $830,968 - $1.26 Million	86,200 Added 27.07%	404,600 $5.71 Million
Q3 2023 Nov 14, 2023	SELL	$10.3 - $15.99 $958,930 - $1.49 Million	-93,100 Reduced 22.62%	318,400 $3.28 Million
Q2 2023 Aug 11, 2023	BUY	$8.48 - $16.48 $833,584 - $1.62 Million	98,300 Added 31.39%	411,500 $6.78 Million
Q1 2023 May 16, 2023	SELL	$6.41 - $9.95 $1.01 Million - $1.58 Million	-158,300 Reduced 33.57%	313,200 $2.87 Million
Q4 2022 Feb 14, 2023	BUY	$5.02 - $10.0 $1.01 Million - $2 Million	200,300 Added 73.86%	471,500 $3.38 Million
Q3 2022 Nov 14, 2022	SELL	$2.57 - $7.31 $1.27 Million - $3.61 Million	-493,900 Reduced 64.55%	271,200 $1.36 Million
Q2 2022 Aug 15, 2022	BUY	$1.07 - $6.95 $599,735 - $3.9 Million	560,500 Added 273.95%	765,100 $1.87 Million
Q1 2022 May 16, 2022	SELL	$5.46 - $8.29 $13,650 - $20,724	-2,500 Reduced 1.21%	204,600 $1.4 Million
Q4 2021 Feb 14, 2022	SELL	$7.34 - $11.18 $1.15 Million - $1.75 Million	-156,600 Reduced 43.06%	207,100 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$6.49 - $9.91 $282,315 - $431,085	43,500 Added 13.59%	363,700 $3.56 Million
Q2 2021 Aug 11, 2021	BUY	$6.73 - $9.05 $971,139 - $1.31 Million	144,300 Added 82.04%	320,200 $2.16 Million
Q1 2021 May 17, 2021	BUY	$6.61 - $10.07 $765,438 - $1.17 Million	115,800 Added 192.68%	175,900 $1.59 Million
Q4 2020 Feb 16, 2021	BUY	$5.03 - $7.95 $243,452 - $384,780	48,400 Added 413.68%	60,100 $401,000
Q3 2020 Nov 16, 2020	SELL	$5.02 - $8.98 $850,387 - $1.52 Million	-169,400 Reduced 93.54%	11,700 $59,000
Q2 2020 Aug 14, 2020	SELL	$7.25 - $11.75 $1.64 Million - $2.66 Million	-226,800 Reduced 55.6%	181,100 $1.46 Million
Q1 2020 May 15, 2020	BUY	$4.06 - $10.64 $1.36 Million - $3.55 Million	334,000 Added 451.96%	407,900 $3.24 Million
Q4 2019 Feb 14, 2020	BUY	$3.34 - $7.7 $193,720 - $446,600	58,000 Added 364.78%	73,900 $558,000
Q3 2019 Nov 14, 2019	SELL	$1.92 - $4.47 $1,920 - $4,470	-1,000 Reduced 5.92%	15,900 $66,000
Q3 2018 Nov 14, 2018	SELL	$4.08 - $7.14 $42,024 - $73,542	-10,300 Reduced 37.87%	16,900 $74,000
Q2 2018 Aug 14, 2018	BUY	$5.89 - $7.78 $73,036 - $96,472	12,400 Added 83.78%	27,200 $167,000
Q1 2018 May 15, 2018	BUY	$6.76 - $11.7 $100,048 - $173,160	14,800 New	14,800 $108,000

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $463M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account